BC
Broadfin Capital Portfolio holdings
AUM
$403M
This Quarter Return
+33.75%
1 Year Return
+74.97%
3 Year Return
+245.63%
5 Year Return
+336.04%
10 Year Return
–
AUM
$758M
AUM Growth
+$758M
(+35%)
Cap. Flow
+$51.5M
Cap. Flow
% of AUM
6.8%
Top 10 Holdings %
Top 10 Hldgs %
45.66%
Holding
77
New
20
Increased
20
Reduced
13
Closed
17
Top Buys
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$18.1M |
| 2 |
Sarepta Therapeutics
SRPT
|
$14.8M |
| 3 |
Dynavax Technologies
DVAX
|
$14.2M |
| 4 |
ZGNX
Zogenix, Inc.
ZGNX
|
$13.4M |
| 5 |
WINT
Windtree Therapeutics Inc
WINT
|
$13.3M |
Top Sells
| 1 |
NTUS
Natus Medical Inc
NTUS
|
$33.9M |
| 2 |
Alkermes
ALKS
|
$15.1M |
| 3 |
Assertio
ASRT
|
$9.28M |
| 4 |
Integra LifeSciences
IART
|
$8.91M |
| 5 |
SPNC
Spectranetics Corp
SPNC
|
$8.33M |
Sector Composition
| 1 | Healthcare | 76.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Assertio
ASRT
$80.4M
| $50.2M | 6.62% | 4,744,772 -877,251 | -16% | -$9.28M |
|
|
LCI
2
DELISTED
Lannett Company, Inc.
LCI
| $44.4M | 5.85% | 1,339,945 +31,384 | +2% | +$1.04M |
|
3
AngioDynamics
ANGO
$417M
| $42.8M | 5.65% | 2,497,049 -329,602 | -12% | -$5.66M |
|
4
Teva Pharmaceuticals
TEVA
$21.1B
| $33.7M | 4.45% | 841,736 +200,000 | +31% | +$8.02M |
|
|
NVDQ
5
DELISTED
Novadaq Technologies Inc.
NVDQ
| $32.5M | 4.28% | 1,969,634 +282,544 | +17% | +$4.66M |
|
|
HZNP
6
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $32.4M | 4.28% | 4,257,469 +2,377,469 | +126% | +$18.1M |
|
|
AVDL
7
Avadel Pharmaceuticals
AVDL
$1.43B
| $30.3M | 4% | 3,767,911 | – | – |
|
|
TTPH
8
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $29.7M | 3.91% | 2,193,328 +400,000 | +22% | +$5.41M |
|
|
ANAC
9
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $25.5M | 3.36% | 1,517,231 -220,438 | -13% | -$3.7M |
|
10
Emergent Biosolutions
EBS
$443M
| $24.7M | 3.26% | 1,074,048 -200 | -0% | -$4.6K |
|
|
NTUS
11
DELISTED
Natus Medical Inc
NTUS
| $22.8M | 3.01% | 1,014,116 -1,506,876 | -60% | -$33.9M |
|
|
PGNX
12
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $21.3M | 2.81% | 4,000,000 +520,652 | +15% | +$2.78M |
|
|
ZGNX
13
DELISTED
Zogenix, Inc.
ZGNX
| $20.2M | 2.67% | 5,875,276 +3,887,631 | +196% | +$13.4M |
|
|
AUXL
14
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $19.9M | 2.63% | 961,100 +150,000 | +18% | +$3.11M |
|
|
IPXL
15
DELISTED
Impax Laboratories, Inc.
IPXL
| $18.5M | 2.43% | 733,929 -188,614 | -20% | -$4.74M |
|
|
WINT
16
DELISTED
Windtree Therapeutics Inc
WINT
| $18.1M | 2.39% | 8,066,000 +5,900,000 | +272% | +$13.3M |
|
|
ACGN
17
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $16.4M | 2.17% | 3,550,000 -975,000 | -22% | -$4.51M |
|
|
18
Sarepta Therapeutics
SRPT
$1.78B
| $14.8M | 1.95% | +726,655 | New | +$14.8M |
|
|
CEMP
19
DELISTED
Cempra, Inc.
CEMP
| $14.4M | 1.9% | 1,164,547 -226,810 | -16% | -$2.81M |
|
|
20
Dynavax Technologies
DVAX
$1.19B
| $14.2M | 1.87% | +7,250,000 | New | +$14.2M |
|
21
Rigel Pharmaceuticals
RIGL
$697M
| $14.1M | 1.86% | 4,955,119 +1,389,300 | +39% | +$3.96M |
|
|
INFI
22
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $13.8M | 1.81% | 996,000 +706,000 | +243% | +$9.75M |
|
|
BDSI
23
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $13.1M | 1.73% | 2,222,054 +100,000 | +5% | +$589K |
|
|
NPSP
24
DELISTED
NPS PHARMACEUTICALS INC
NPSP
| $12.1M | 1.6% | 400,000 -51,597 | -11% | -$1.57M |
|
25
TherapeuticsMD
TXMD
$12.8M
| $11.1M | 1.46% | 2,128,159 | – | – |
|